Design
Review
Authors
Loading...
Aspirin use remains supported; leaves open whether targeting other oxylipins improves outcomes in obesity or diabetes.
Key points are not available for this paper at this time.
Tourdot et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: